Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Dr Line Melgaard MSc, PhD graduated from the University of Aalborg in 2013 with a master degree in Medicine with Industrial Specialization. Dr Melgaard received a PhD-degree from Aalborg University in 2016 (title: “Thromboembolic risk in heart failure patients without atrial fibrillation”). During her PhD, she used Danish nationwide registry data to investigate predictors of ischemic stroke and… View more
Job title: PhD
Gary E Raskob's research and scholarly interests are in the prevention, diagnosis and treatment of deep-vein thrombosis and pulmonary embolism; the clinical development of antithrombotic drugs; clinical trials; prevention research; evidence-based medicine; and the translation of research evidence into practice and health policy. Gary E Raskob has participated extensively in clinical practice… View more
Job title: Associate Professor of Cardiovascular Surgery
Dr Mert Dumantepe is an Associate Professor of Cardiovascular Surgery at Acibadem University School of Medicine, Turkey. He completed his graduation from Istanbul University School of Medicine, Turkey in 2001. He did a fellowship in chronic thromboembolic pulmonary hypertension and pulmonary endarterectomy and the heart transplantation and mechanical asist device programme at the University of… View more
Research Area(s) / Expertise:

Deep

Venous Disease - General

Thrombosis, embolism & bleeding

Job title: Associate Professor of Radiology, Surgery and Medicine; Director, Deep Venous Interventions
Dr Kush R Desai, MD, FSIR is an Interventional Radiologist and Associate Professor of Radiology, Surgery, and Medicine at Northwestern University. His primary research and clinical interests are in venous thromboembolic disease, deep venous thrombectomy/thrombolysis, reconstruction of chronic venous occlusions, IVC filter management/complex IVC filter retrieval, and interventional pulmonary… View more
Author(s): Line Melgaard Added: 5 years ago
Dr Line Melgaard (Aalborg University, Aalborg, DK) discusses the thromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition. Filmed on site at EHRA 2019 by Radcliffe Cardiology Questions: 1. What was the need to evaluate atrial fibrillation patients specifically with valvular heart disease? 2. How was the study set up to… View more
Author(s): Ole De Backer Added: 4 years ago
Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) provides an update from theGALILEO-4D trial, discussing the comparison ofa Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves. What is the GALILEO-4D study and how is it related to the main GALILEO trial? What is the design of the study and what… View more
Author(s): Stuart J Head , Ad JJC Bogers , A Pieter Kappetein Added: 3 years ago
Valvular Heart Surgery The field of cardiac surgery is urgently in need of new anticoagulant agents. Approximately 300,000 prosthetic valves are implanted yearly, after which lifelong anticoagulation therapy is mandatory as thromboprophylaxis. To date, vitamin K antagonists (VKAs), such as warfarin, remain the only licensed agents to prevent mechanical valve-induced thromboembolic events but… View more